US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.00

+1.303.36%

Post-market: 40.000.00000.00%17:15 EDT

Volume:63.45K

Turnover:2.54M

Market Cap:270.00M

PE:- -

High:40.58

Open:39.41

Low:39.41

Close:38.70

52wk High:41.49

52wk Low:22.33

Shares:6.75M

Float Shares:6.75M

Volume Ratio:0.43

T/O Rate:0.94%

Dividend:0.28

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Incyte R&D President Pablo J. Cagnoni Disposes of 23,218 Common Shares Worth $2.8 Million

Ultragenyx confirms FDA approval of Fayuvi

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Moderna Shares Hit Four-Week High; Last up 8%

THOMSON REUTERS

Twist Bioscience Price Target Raised to $160.00/Share from $120.00 by Leerink Partners

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)

Hemab Therapeutics doses first patient in HMB-003 trial

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

Fennec presents results from STS-J01 clinical trial evaluating Pedmark

Twist Bioscience Corporation : Leerink Partners Raises Target Price to $160 from $120

THOMSON REUTERS

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream

MT Newswires Live

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/IDNA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":40,"timestamp":1789675200000,"preClose":38.7,"halted":0,"volume":63447,"hourTrading":{"tag":"盘后","latestPrice":40,"preClose":40,"latestTime":"17:15 EDT","volume":203,"amount":8225.49,"timestamp":1789679712782,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.033591731266149796,"floatShares":6750000,"shares":6750000,"eps":0,"marketStatus":"Not Yet Opened","change":1.3,"latestTime":"09-17 16:00:00 EDT","open":39.41,"high":40.58,"low":39.41,"amount":2543963,"amplitude":0.030233,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.7,"sharesOutstanding":5100000,"nav":38.722209,"aum":263311021.2,"dividendRate":0.007043,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.4759,"preClose":38.7,"latestTime":"09:24 EDT","volume":300,"amount":11772.18,"timestamp":1789651453690,"change":0.7759,"changeRate":0.020049,"amplitude":0.01824},"postHourTrading":{"tag":"盘后","latestPrice":40,"preClose":40,"latestTime":"17:15 EDT","volume":203,"amount":8225.49,"timestamp":1789679712782,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.426999,"impliedVol":0.275,"impliedVolPercentile":0.788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.426999,"shares":6750000,"dividePrice":0.2817,"high":40.58,"amplitude":0.030233,"preClose":38.7,"low":39.41,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":40,"eps":0,"divideRate":0.007043,"volume":63447,"delay":0,"ttmEps":0,"open":39.41,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":37.88,"twentyDayClose":40.75,"sixtyDayClose":31.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU2468319806.SGD","SG9999001176.SGD","IDNA","LU0432979614.USD","BK4567","LU2236285917.USD","IE0002270589.USD","LU2362540622.SGD","LU1674673691.USD","IE00B894F039.SGD","BK4139","LU1035775433.USD","LU2462157665.USD","SGXZ57979304.SGD","BBH","LU1778281490.HKD","IE0002141913.USD","IE00BZ9MQY76.HKD","LU0079474960.USD","IBBQ","LU1815336091.USD","LU2089984988.USD","LU0058720904.USD","IE0009355771.USD","IBB","LU0757428866.USD","PBE","IE00B19Z9Z06.USD","LU0289739699.SGD","IE00B19Z9P08.USD","BK4532","LU1430594728.SGD","LU2362541513.USD","LU0109394709.USD","BIB","VRTX","GNMX","SG9999001176.USD","IE00BJT1NW94.SGD","SG9999013999.USD","LU1069344957.HKD","LU1559883803.SGD","BK4585","LU0889565916.HKD","LU2237438978.USD","TBXU","VERX","BK4533","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668990195","title":"Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2668990195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668990195?lang=en_us&edition=fundamental","pubTime":"2026-09-18 06:33","pubTimestamp":1789684401,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has provided an announcement. Vortex Energy Corp. has entered into an asset purchase agreement to acquire the M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-moves-to-acquire-saskatchewan-meadows-project-for-future-energy-storage-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0417517546.SGD","LU1093756325.SGD","LU1674673428.USD","GNMX","SG9999013999.USD","PBE","LU2468319806.SGD","LU2417539215.USD","TBXU","IE00B4R5TH58.HKD","IE0002270589.USD","SGXZ57979304.SGD","BBH","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","LU0256863811.USD","BK4139","LU0432979614.USD","LU2362541513.USD","VRTX","SG9999001176.USD","LU1585245621.USD","IBB","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU2456880835.USD","LU2462157665.USD","LU0823416689.USD","SG9999001176.SGD","LU1430594728.SGD","IE00B894F039.SGD","LU2236285917.USD","IBBQ","IE00BJT1NW94.SGD","LU0058720904.USD","LU2362541273.HKD","LU0079474960.USD","BK4567","BK4585","LU2324357040.USD","LU2237438978.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","BIB","BK4588","IDNA","BK4532","LU0109394709.USD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668992940","title":"Moderna Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668992940","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668992940?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:33","pubTimestamp":1789677180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.This was the stock's second consecutive day of gains.Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","MRNY","IBBQ","LU0965509101.SGD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU1061106388.HKD","GNOM","LGHT","SG9999015945.SGD","LU0859254822.USD","LU0320765992.SGD","MRNA","SG9999015986.USD","LU0823416689.USD","LU2324357040.USD","WDNA","LU2089984988.USD","LU0114720955.EUR","LU0965509010.AUD","LU0882574055.USD","BBH","IDNA","BIB","BK4566","LU1934455863.HKD","LU1037948897.HKD","LU2357627491.SGD","LU0289739699.SGD","BK4568","IE00BSNM7G36.USD","LU1585245621.USD","MRNX","BK4551","IBB","LU0234570918.USD","LU0122379950.USD","LU0889565916.HKD","BK4578","LU1839511570.USD","TMED","LU1674673428.USD","BK4501","MEDI","IE00B7SZLL34.SGD","GILD","LU0861579265.USD","BK4534","LU1778281490.HKD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668033994","title":"Incyte R&D President Pablo J. Cagnoni Disposes of 23,218 Common Shares Worth $2.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668033994","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668033994?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:05","pubTimestamp":1789675525,"startTime":"0","endTime":"0","summary":"Incyte R&D President Pablo J. Cagnoni disposes of 23,218 common shares worth $2.8 millionPablo J. Cagnoni, President and Global Head of R&D, cut his Incyte stake to 183,200 shares on Sept. 15, 2026.He","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDLcbwHF5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Incyte R&D President Pablo J. Cagnoni Disposes of 23,218 Common Shares Worth $2.8 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IDNA","BK4139","BK4550","INCY","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994030","title":"Ultragenyx confirms FDA approval of Fayuvi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994030","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994030?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:55","pubTimestamp":1789674924,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) announced that the U.S. FDA granted standard full approval of Fayuvi, also known as UX111, for the treatment of pediatric patient...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-confirms-fda-approval-of-fayuvi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","PSCH","RSPH","NVIB","PINK","IBB","IYH","BK4139","TECB","IDNA","MEDI","BK4585","TBXU","BBP","XLVX","RARE","LFSC","BMED","IEIH","MRNX","LABU","FRTY","GNMX","BK4588","GDOC","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668299493","title":"S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2668299493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668299493?lang=en_us&edition=fundamental","pubTime":"2026-09-18 03:30","pubTimestamp":1789673408,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeGenerac Holdings Inc.GNRC.N+18.8%Super Micro Computer IncSMCI.OQ+9.8%Intel CorpINTC.OQ+8.5%Hewlett Packard Enterprise CompanyHPE.N+8.4%Moderna, Inc.MRNA.OQ+7.4%Bottom PerformersPercent ChangeDaVita IncDVA.N-5.5%T-Mobile US IncTMUS.OQ-5.4%Builders FirstSource IncBLDR.N-3.8%Copart IncCPRT.OQ-3.6%Reddit, Inc.RDDT.N-3.4%As of 03:30 p.m., the S&P 500.SPXgained 85.76 points, or 1.14%, to 7,637.57 and had posted 12 new 52-week highs and 19 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL8N45922E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSO","DBSC","BK4543","LU2244417387.USD","LU2764263203.CNY","FTXL","LU0006061336.USD","IVE","LU0823414478.USD","RDTL","LU2290526834.HKD","SPYD","LU0082616367.USD","XYLD","IE00B3S45H60.SGD","BK4132","BK4559","BMAY","BK4554","LU0061474705.USD","BK4077","RDDC","SMCL","LU1621767810.EUR","GNRC","LU1066051811.HKD","LU1878469433.USD","INT","MRNX","TMUS","LU0310800379.SGD","LU1988902786.USD","VOO","INTW","LU1066051498.USD","BK4527","IE00B775SV38.USD","LU1035773651.USD","DMAX","LU1621768115.EUR","IE000MB6IJN5.SGD","LU2317271919.USD","DRIV","BK4548","LU0314106906.USD","LU0719512351.SGD","BK4605","LU0128525929.USD","LU1861215975.USD","SMCI","LU0642271901.SGD","BK4551","SPXL","SOCL","LU2543165471.USD","LU0251131958.USD","MMAX","LU0048573561.USD","ACWI","BLDR","MOAT","SPMO","VTI","LU0097036916.USD","LU2264538146.SGD","LU2720916845.USD","SPYM","XDTE","YSPY","SMCX","IJH","NOBL","IVW","BK4139","LU0251142724.SGD","HIBL","LU2098885051.SGD","AIQ","BK4196","SMYY","LU1316542783.SGD","LU0056508442.USD","BK4086","LU0266013472.USD","IE000M9KFDE8.USD","LU2087625088.SGD","LU0225771236.USD","HK0000304797.USD","LU1303367103.USD","SFY","LU0786609619.USD","HPEL","LU2361044865.SGD","LU2394011477.USD","LU0823421333.USD","LU0985481810.HKD","IE0008368304.USD","SPHD","LU0276348264.USD","SCHB","LU2357627491.SGD","LU1506573853.SGD","SMCZ","BK4501","IE00BMPRXN33.USD","LU2249611893.SGD","SPYV","VTV","BK4512","IE0000B7K699.USD","IE000BZT7R73.USD","IDNA","LU0225284248.USD","LU0321505439.SGD","LU1069347547.HKD","LU0187121727.USD","SMAX","SMCC","LU0353189763.USD","CHPS","SPYQ","LU2360108059.USD","BK4096","RSPA","IE000SO60NU8.SGD","BK4532","BK4141","LU0306807586.USD","LGHT","LU1066051225.USD","SPXU","LU2250418816.HKD","CNRG","LU0077335932.USD","RSPN","LEGR","LU1066053197.SGD","SINTCmain","LU2764263039.SGD","LU0868494617.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU0859254822.USD","XNTK","ITOT","UPRO","BK4550","LU2361045086.USD","LINT","LU1064131342.USD","BK4547","LU1267930573.SGD","SPGP","SPHQ","VEU","LU0823421416.USD","LU1983260115.SGD","LU0321505868.SGD","LU2361044949.HKD","LU0127658192.USD","LU0708994859.HKD","QQQA","BK4568","BK4137","IE000F7OJYX1.SGD","BK4588","LU0306806265.USD","DVA","LU2089985449.USD","LU2148611432.USD","LU1852331112.SGD","LU0053671581.USD","LU2384288077.EUR","IJR","LU0154236417.USD","LU0640476718.USD","GNOM","SPDN","SPY","XLG","XHB","SPYH","GPIX","LU2210149790.SGD","SDS","BK4602","LU2247934214.USD","BK4535","IE00BMPRXQ63.HKD","BK4549","GSLC","LU0323239441.USD","LU2092937221.SGD","LU2298321311.HKD","LU0320765489.SGD","LU0353189680.USD","BK4561","LU0348723411.USD","BK4533","LU0267386448.USD","HIBS","RDYY","RSP","LU0742534661.SGD","VBK","CPRT","SMCY","LU0170899867.USD","LU0149725797.USD","VOOG","LU1621768206.USD","SPLV","SPYU","LU0274383776.USD","SPXS","ETFT","LU2764262908.HKD","SPUU","04335","WDNA","JEPI","BK4515","SH","LU1861220033.SGD","BK4585","LU2931357623.SGD","BK4579","LU0081259029.USD","BK4529","MRNY","RSPU","BK4534","SOXX","INTC","TTEQ","LU0323240290.USD","TSPY","LU1280957306.USD","LU0029864427.USD",".SPX","SCHX","RDDT","BK4612","SPUS","ALLW","SPYG","INYY","LU2041044095.USD","LU2095319765.USD","IE00BMPRXR70.SGD","HPE","HK0000304805.HKD","MRNA","IE000WAW04H5.SGD","VV","IVV","LU2360106780.USD","AIS","LU2210150020.SGD","BK4575","LU0070302665.USD","LU1814569148.SGD","LU2360107168.USD","BK4170","LU1621767737.EUR","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668913409","title":"Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2668913409","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668913409?lang=en_us&edition=fundamental","pubTime":"2026-09-18 01:15","pubTimestamp":1789665324,"startTime":"0","endTime":"0","summary":"• Macroeconomic tailwinds and risk-on sentiment drove Moderna's strong upward rally and volatility.\n• Positive late-stage clinical data for intismeran expanded valuation expectations for oncology.\n• Analyst upgrades and institutional demand absorbed selling pressure from routine insider sales.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262173707-market-movers-mrna-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","BK4501","BK4568","BK4585","BK4588","BK4534","MRNA","LGHT","MRNY","IDNA","WDNA","MRNX","BK4139","BK4533","BK4551","BK4532","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999169","title":"Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999169?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:44","pubTimestamp":1789663452,"startTime":"0","endTime":"0","summary":"Longeveron stock took a 56.14% beating on Thursday after the company posted a failed clinical trial.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/longeveron-stock-lgvn-plummets-56-on-a-failed-clinical-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/longeveron-stock-lgvn-plummets-56-on-a-failed-clinical-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","GDOC","NVIB","HYLG","BK4139","LGVN","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999880","title":"Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999880","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999880?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:32","pubTimestamp":1789662720,"startTime":"0","endTime":"0","summary":"Moderna stock abruptly rallied on Thursday, pacing toward its best session since a positive update for its experimental cancer vaccine sent shares skyrocketing.Look to no other explanation than a mome","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","IE00BN8TJ469.HKD","LU1162221912.USD","LU2491050071.SGD","SGXZ57979304.SGD","LU0162691827.USD","RXL","FTXH","LGHT","IYH","LU1983299246.USD","LU1934455277.USD","IXJ","LU0861579265.USD","LU1571399168.USD","SG9999013999.USD","MRNA","IE00B1BXHZ80.USD","FHLC","IDNA","VHT","TRUH","BK4534","SG9999014575.USD","LU2125909247.SGD","LU1037948897.HKD","GNOM","BK4551","LU1032466523.USD","LU2125909593.SGD","XLV","HRTS","LU1974910355.USD","IHE","LU2106854487.HKD","PPH","MRNX","LU0069063385.USD","WDNA","JDOC","BMED","GDOC","LU0124676726.USD","MRK","MRNY","PAWZ","SG9999001176.USD","LU0211331839.USD","LU1201861249.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668399537","title":"Moderna Shares Hit Four-Week High; Last up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668399537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668399537?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:09","pubTimestamp":1789657789,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N4591AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNOM","BK4551","BK4568","BK4139","BK4585","BK4533","BK4532","MRNY","BK4588","LGHT","MRNA","BK4548","IDNA","MRNX","WDNA","BK4534","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668599327","title":"Twist Bioscience Price Target Raised to $160.00/Share from $120.00 by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2668599327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668599327?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:50","pubTimestamp":1789656600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TWST/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","IDNA","BK4585","WDNA","GNOM","BK4588","BK4139","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996274","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996274?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:30","pubTimestamp":1789648219,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS), Twist Bioscience (TWST) and Medpa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-twist-bioscience-twst-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","IBRN","XBI","XLV","FBT","ALKS","BK4139","BK4137","LU2065171311.SGD","LU2065169927.USD","ARKG","BK4588","BK4581","LABU","PSCH","MEDX","TWST","WDNA","HCSG","MEDP","IDNA","LU2065170008.USD","PSIL","BK4121","LU2065171402.SGD","LU0128526141.USD","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668196234","title":"Hemab Therapeutics doses first patient in HMB-003 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668196234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668196234?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:05","pubTimestamp":1789646751,"startTime":"0","endTime":"0","summary":"Hemab Therapeutics (COAG) announced that the first healthy volunteer has been dosed in its Phase 1 clinical trial evaluating HMB-003, an investigat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hemab-therapeutics-doses-first-patient-in-hmb-003-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hemab-therapeutics-doses-first-patient-in-hmb-003-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COAG","BK4139","BK4539","GDOC","LENZ","NVIB","BK4007","MEDX","HYLG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668996120","title":"Nuvation Bio announces FDA approval of sNDA for Ibtrozi","url":"https://stock-news.laohu8.com/highlight/detail?id=2668996120","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668996120?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644932,"startTime":"0","endTime":"0","summary":"Nuvation Bio (NUVB) announced that the U.S. FDA has approved a supplemental New Drug Application for Ibtrozi, a ROS1 inhibitor approved for the tre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuvation-bio-announces-fda-approval-of-snda-for-ibtrozi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","BK4007","MRNX","GDOC","BBP","BK4588","MEDI","RSPH","TBXU","LABU","BK4585","IBB","NUVB","SYNB","TECB","MRNY","BMED","XLVX","GNMX","FRTY","IDNA","IYH","NVIB","LFSC","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668196173","title":"Fennec presents results from STS-J01 clinical trial evaluating Pedmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2668196173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668196173?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:35","pubTimestamp":1789644911,"startTime":"0","endTime":"0","summary":"Fennec (FENC) announced the oral presentation of detailed results from the investigator-initiated Phase 2 STS-J01 clinical trial evaluating Pedmark...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fennec-presents-results-from-sts-j01-clinical-trial-evaluating-pedmark-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fennec-presents-results-from-sts-j01-clinical-trial-evaluating-pedmark-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","HYLG","NVIB","BK4139","FENC","IDNA","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969362","title":"Twist Bioscience Corporation : Leerink Partners Raises Target Price to $160 from $120","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969362?lang=en_us&edition=fundamental","pubTime":"2026-09-17 18:59","pubTimestamp":1789642783,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDNA","IDNA","GNOM","BK4585","ARKG","BK4588","BK4139","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","COPP","IBB","LU0823416689.USD","LU2236285917.USD","CPER","BBH","CPXR","LU0432979614.USD","UYM","LU2417539215.USD","LU0566484027.USD","XME","IE0002270589.USD","VERX","LU2324357040.USD","BK4532","IE00B19Z9Z06.USD","TBXU","LU1093756168.USD","LU1035775433.USD","IBBQ","ICOP","BIB","COPJ","LU2462157665.USD","LU1430594728.SGD","LU0256863811.USD","BK4023","IE00B2B36J28.USD","LU1069344957.HKD","BK4139","VRTX","IE0009355771.USD","QCmain","GNMX","IE00B894F039.SGD","SG9999013999.USD","PBE","IE00BFTCPJ56.SGD","LU1778281490.HKD","IDNA","LU2089984988.USD","MHGmain","LU0889565916.HKD","LU2237438978.USD","LU2468319806.SGD","LU1093756325.SGD","LU0320765992.SGD","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","LFSC","TECB","PINK","GNMX","TBXU","IYH","IEIH","SYNB","MEDI","NVIB","GDOC","XLVX","BMED","MRNX","FRTY","PSCH","RSPH","BK4007","BK4585","LABU","IBB","BBP","IDNA","BAYRY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668959271","title":"Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2668959271","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668959271?lang=en_us&edition=fundamental","pubTime":"2026-09-17 14:17","pubTimestamp":1789625847,"startTime":"0","endTime":"0","summary":"Bailing Yuxiu  Pharmaceutical, a wholly-owned subsidiary of Guizhou Bailing Group Pharmaceutical , has received approval from China's National Medical Products Administration to conduct clinical trials of Tangning Tongluo Cream for diabetic foot ulcers, according to a Wednesday filing with the Shenzhen bourse.Tangning Tongluo is a traditional Chinese medicine drug available in tablet and cream formulations for diabetes-related conditions.The clinical trial application was approved subject to further refinement of the trial protocol.In November 2024, the company received NMPA approval to conduct a Phase III clinical trial of Tangning Tongluo tablets for diabetic retinopathy. In October 2025, it received approval to conduct clinical trials of Tangning Tongluo tablets for Type 2 diabetes.The company said the cream could potentially complement its Tangning Tongluo tablets to form an \"oral plus topical\" treatment system.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK0077","GDOC","HYLG","IDNA","NVIB","BK0239","MEDX","BK0183","BK0188","BK0146","002424"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936994","title":"Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936994?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:35","pubTimestamp":1789594520,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced topline results from ELPIS II, its Phase 2b clinical trial evaluating its investigational stem cell therapy laromestroc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","CNCR","GDOC","MEDX","FBT","LGVN","IBB","LFSC","SYNB","BK4139","GNOM","IDNA","NVIB","TBXU","BK4588","IBBQ","HYLG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}